Long-term view allows Temasek to be patient with poor performers
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
TEMASEK Holdings can stay the course with its poor performers because it invests for the long term.
The point was made at Temasek's annual review on Tuesday, after shares of German life science giant Bayer had fallen by 39 per cent since April 2018, when Temasek put an additional three billion euros (S$4.8 billion) into the company.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
20 photos that show how dramatically Singapore has changed in two decades
Singapore’s key exports up 15.3% in March from electronics surge, exceeding forecasts
